CoChat
Sign Up
Cited by 172Lipid metabolism and disordersLipoproteins and Cardiovascular HealthLipid metabolism and biosynthesis

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins

Tornvall, Per, Olivecrona, Gunilla, Karpe, Fredrik, Hamsten, Anders, Olivecrona, Thomas·1995·Arteriosclerosis, Thrombosis, and Vascular Biology
DOI 10.1161/01.atv.15.8.1086
Open this paper in CoChat — free account

Abstract

Abstract Lipoprotein lipase (LPL) activity and mass in plasma and their increase after heparin administration were measured in 61 men who had suffered myocardial infarction before the age of 45 years and in 69 population-based age- and sex-matched control subjects without coronary heart disease to study the relations between these parameters in plasma and their correlations with plasma lipoproteins in subjects with a wide range of lipoprotein and LPL levels. There was a relatively large amount of LPL protein compared with LPL activity in preheparin plasma, indicating that the majority of circulating LPL is catalytically inactive. LPL mass and activity in postheparin plasma (postheparin minus preheparin values) were highly correlated, and the calculated mean specific activity (0.35 mU/ng) was in the range expected for catalytically active LPL. Hence, heparin releases mainly active LPL. The four LPL parameters (mass and activity in plasma and their increase after heparin administration) were not related to each other, except for postheparin plasma LPL mass and activity, and they showed different correlations with plasma lipoprotein lipid concentrations. There was a strong positive correlation between LPL mass in preheparin plasma and the HDL cholesterol level as well as weak negative relations to VLDL triglyceride and cholesterol concentrations in the patients. In contrast, preheparin LPL activity showed no correlation with the HDL cholesterol level but weak positive relations to VLDL triglyceride and cholesterol concentrations in the control subjects. Postheparin plasma LPL activity related positively to the HDL cholesterol level and negatively to the VLDL triglyceride concentration in the control subjects. Case subjects differed from control subjects in that they had higher preheparin plasma LPL activity and a tendency toward lower specific activity of postheparin plasma LPL. The different relations of the measured LPL parameters to plasma lipoproteins and the difference in preheparin plasma LPL activity between patients and control subjects might reflect a disturbance of the LPL system in the patients.

Overview

Integrity signals

Registry

Crossref · 10.1161/01.atv.15.8.1086

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 6

  1. 10.1161/atv91.12.10.1390589 · DOI
  2. 1976, Clin Sci Mol Med, 50, 249
  3. 1988, Am J Physiol, 254, G711
  4. Hamsten A. Studies on Myocardial Infarction at Young Age: Metabolic Haemostatic and Familial Factors in Post-Infarction Patients Below the Age of 45 . Stockholm Sweden: Karolinska Institute; 1986. Thesis.
  5. 1953, J Lab Clin, 41, 486
  6. 10.1161/atv91.11.3.2029503 · DOI

Cited by

Sorted by citations

Items 101–172 of 172

Related

See all

Metadata

Authors
Tornvall, P., Olivecrona, G., Karpe, F., Hamsten, A., & Olivecrona, T.
Affiliations
Karolinska Institutet (SE)
ORCID
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1995-08
Volume
15
Issue
8
Pages
1086-1093
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
DOI
10.1161/01.atv.15.8.1086
OpenAlex
W2059234590
Cited by
172
References
55
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 7 · 2019: 6 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 9 · 2013: 6 · 2012: 3
FWCI
5.49
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
lipoprotein lipase, lipoprotein lipase activity, HDL cholesterol, VLDL triglycerides, VLDL cholesterol, serum lipoproteins, myocardial infarction, young men
MeSH terms
Adult, Coronary Disease, Heparin, Humans, Lipoprotein Lipase, Lipoproteins, Male, Middle Aged, Myocardial Infarction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review